Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?

This publication has 26 references indexed in Scilit:

• Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer
  JAMA, 2013
• Axillary Lymph Node Status, Adjusted for Pathologic Complete Response in Breast and Axilla after Neoadjuvant Chemotherapy, Predicts Differential Disease-Free Survival in Breast Cancer
  Current Oncology, 2013
• Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
  The Lancet Oncology, 2013
• Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging
  Radiology, 2011
• Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
  Journal of Clinical Oncology, 2011
• Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
  JAMA, 2011
• MRI-Model to Guide the Surgical Treatment in Breast Cancer Patients After Neoadjuvant Chemotherapy
  Annals of Surgery, 2010
• Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
  Journal of Clinical Oncology, 2008
• Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
  The Lancet Oncology, 2007
• Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
  JNCI: Journal of the National Cancer Institute, 2006